This small cap ASX healthcare share is racing higher following a coronavirus update

The Medical Developments International Ltd (ASX:MVP) share price is racing higher today after providing an update on the impact of the coronavirus…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Medical Developments International Ltd (ASX: MVP) share price is pushing higher on Tuesday after releasing an update on the impact of the coronavirus on its business.

At the time of writing the healthcare company's shares are up 3.5% to $5.12.

What did Medical Developments International announce?

This morning Medical Developments International revealed that at this stage the potential negative impact of the COVID-19 virus on its business appears to be limited.

In respect to inventory, management advised that it has been building stock to cater for an anticipated increase in sales throughout calendar year 2020. It also has sufficient stocks of raw materials and finished goods on hand to meet forecast demand.

In addition to this, it notes that key suppliers remain open for business and the company continues to receive supplies and is fulfilling orders.

And while some of its raw material stock is directly imported from the China market, those materials are held in sufficient quantities to maintain production throughout calendar year 2020.

In respect to sales, the company has experienced a negative impact on a very small level of sales to China for the Veterinary business. Pleasingly, though, it has not yet experienced a decline in demand for its key pharmaceutical and medical products.

Management also provided an update on its clinical programs. It advised that the clinical programs underway in China, UK, Europe and South Korea have been disrupted by the coronavirus outbreak. These are either on provisional hold or being delayed as local medical authorities and services in these countries focus on COVID-19.

Positively, at this stage the company has not been advised of any delays from the U.S. FDA.

What now?

Medical Developments International advised that it is busy developing contingency plans to manage the ongoing risk faced by the business.

It also revealed that its staff are avoiding any non-essential travel and rostering has been implemented. Other than this, it appears to be business as usual for the company.

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of Medical Developments International Limited. The Motley Fool Australia has recommended Medical Developments International Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

A happy young couple lie on a wooden deck using a skateboard for a pillow.
Share Gainers

These were the best-performing ASX 200 shares in March

These shares made their shareholders smile in March thanks to some very big gains.

Read more »

Stock market chart in green with a rising arrow symbolising a rising share price.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a massive day for the ASX 200, with a new all-time high recorded.

Read more »

A man sits thoughtfully on the couch with a laptop on his lap.
Technology Shares

This ASX tech stock rocketed 60% in March! Can it keep on delivering?

After soaring in March, the ASX tech stock is now up 169% since this time last year.

Read more »

A young women pumps her fists in excitement after seeing some good news on her laptop.
Share Gainers

Why Mesoblast, Newmont, Pilbara Minerals, and Platinum shares are jumping

These ASX shares are ending the week strongly. But why?

Read more »

A young male ASX investor raises his clenched fists in excitement because of rising ASX share prices today
Share Gainers

3 ASX All Ords shares up 50%+ in March

These ASX shares have been on fire this month. But why?

Read more »

Woman looks amazed and shocked as she looks at her laptop.
Share Gainers

Why Mesoblast, Patriot Battery Metals, Sigma, and Zip shares are pushing higher

These shares are having a good session on hump day. But why?

Read more »

Woman looks amazed and shocked as she looks at her laptop.
Consumer Staples & Discretionary Shares

If you'd put $20,000 in this ASX retail stock at the start of 2023, you'd have $134,000 now

This online retailer has executed a remarkable turnaround for its investors.

Read more »

Fancy font saying top ten surrounded by gold leaf set against a dark background of glittering stars.
Share Gainers

Here are the top 10 ASX 200 shares today

It was back to earth for ASX shares this Tuesday.

Read more »